A clinical trial designed to test existing drugs in the treatment of a rare blood cancer has been launched at the Universities of Warwick and Birmingham.
University of Warwick miscarriage expert meets Duchess of Cambridge during visit to London miscarriage research centre
A University of Warwick expert in pregnancy and miscarriage joined scientists in meeting Her Royal Highness The Duchess of Cambridge during a visit to a miscarriage research centre in London.
New UK Hospital at Home Society to hold its first virtual conference co-organised by Warwick researcher
Promoting the increasingly recognised alternative to in-patient care, the newly established UK Hospital at Home Society is holding its first virtual conference on 8th October, co-organised by a University of Warwick researcher who will also contribute to the conference with a discussion on Point of Care diagnostic tests in the home and care home.
A researcher at Warwick Medical School is involved in a new study to explore the effectiveness of the anti-tumour necrosis factor (anti-TNF) drug adalimumab as a treatment for patients with COVID-19 in the community, especially care homes.
NanoSyrinx, an emerging biotechnology company developing new therapeutic modalities for Cell & Gene editing, has secured funding to further develop a novel technology for delivering treatments spun out from research at Warwick Medical School at the University of Warwick.